ATE203898T1 - Verfahren zur herstellung einer liposomen- zubereitung - Google Patents
Verfahren zur herstellung einer liposomen- zubereitungInfo
- Publication number
- ATE203898T1 ATE203898T1 AT96918002T AT96918002T ATE203898T1 AT E203898 T1 ATE203898 T1 AT E203898T1 AT 96918002 T AT96918002 T AT 96918002T AT 96918002 T AT96918002 T AT 96918002T AT E203898 T1 ATE203898 T1 AT E203898T1
- Authority
- AT
- Austria
- Prior art keywords
- liposome preparation
- producing
- portions
- liposome
- encapsulated
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 6
- 238000002360 preparation method Methods 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000463 material Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 238000012377 drug delivery Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000000887 hydrating effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2984—Microcapsule with fluid core [includes liposome]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/475,581 US6007838A (en) | 1995-06-07 | 1995-06-07 | Process for making liposome preparation |
| PCT/US1996/008622 WO1996040063A1 (en) | 1995-06-07 | 1996-06-06 | Process for making liposome preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE203898T1 true ATE203898T1 (de) | 2001-08-15 |
Family
ID=23888222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96918002T ATE203898T1 (de) | 1995-06-07 | 1996-06-06 | Verfahren zur herstellung einer liposomen- zubereitung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6007838A (de) |
| EP (1) | EP0831779B2 (de) |
| JP (1) | JP2000514035A (de) |
| AT (1) | ATE203898T1 (de) |
| AU (1) | AU699055B2 (de) |
| CA (1) | CA2223808A1 (de) |
| DE (1) | DE69614385T3 (de) |
| DK (1) | DK0831779T4 (de) |
| ES (1) | ES2159358T3 (de) |
| IL (1) | IL122486A (de) |
| PT (1) | PT831779E (de) |
| WO (1) | WO1996040063A1 (de) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE554748T1 (de) * | 1997-11-14 | 2012-05-15 | Pacira Pharmaceuticals Inc | Herstellung von multivesikulären liposomen |
| US8178150B2 (en) | 2000-02-22 | 2012-05-15 | Suzanne Jaffe Stillman | Water containing soluble fiber |
| US7115297B2 (en) | 2000-02-22 | 2006-10-03 | Suzanne Jaffe Stillman | Nutritionally fortified liquid composition with added value delivery systems/elements/additives |
| US7892586B2 (en) | 2001-02-22 | 2011-02-22 | Suzanne Jaffe Stillman | Water containing soluble fiber |
| US8642051B2 (en) | 2000-03-21 | 2014-02-04 | Suzanne Jaffe Stillman | Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s) |
| IL151633A0 (en) | 2000-03-21 | 2003-04-10 | Stillman Suzanne Jaffe | Infusion packet with useful and decorative elements, support member delivery system and method |
| US20040022838A1 (en) * | 2001-06-20 | 2004-02-05 | Holick Michael F. | Regulation of cell proliferation and differentiation using topically applied peptides |
| EP1365794A2 (de) * | 2000-07-21 | 2003-12-03 | Lue, Tom | Vorbeugung und behandlung von störungen der sexuellen erregbarkeit |
| US7223406B2 (en) | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
| US20040082521A1 (en) * | 2002-03-29 | 2004-04-29 | Azaya Therapeutics Inc. | Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases |
| US20030219696A1 (en) * | 2002-05-23 | 2003-11-27 | Moreland Gerald W. | Method and apparatus for preventing backflow in dental saliva evacuators |
| DE60334618D1 (de) | 2002-06-28 | 2010-12-02 | Protiva Biotherapeutics Inc | Verfahren und vorrichtung zur herstellung von liposomen |
| DE20321889U1 (de) | 2002-08-02 | 2012-03-12 | Glaxosmithkline Biologicals S.A. | Impfstoffzusammensetzung |
| US7179484B2 (en) * | 2002-11-06 | 2007-02-20 | Azaya Therapeutics, Inc. | Protein-stabilized liposomal formulations of pharmaceutical agents |
| WO2007012191A1 (en) | 2005-07-27 | 2007-02-01 | Protiva Biotherapeutics, Inc. | Systems and methods for manufacturing liposomes |
| WO2007049279A2 (en) * | 2005-10-26 | 2007-05-03 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | A liposomal combination and uses thereof |
| EP2032161B1 (de) | 2006-06-12 | 2012-07-11 | GlaxoSmithKline Biologicals S.A. | L3v los impfstoffe |
| NO329127B1 (no) * | 2006-09-12 | 2010-08-30 | Epitarget As | Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel |
| US9744142B2 (en) | 2009-05-05 | 2017-08-29 | Board Of Regents, The University Of Texas Systems | Formulations of volatile anesthetics and methods of use for reducing inflammation |
| CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
| DK2691530T3 (en) | 2011-06-10 | 2018-05-22 | Univ Oregon Health & Science | CMV GLYCOPROTEIN AND RECOMBINANT VECTORS |
| US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
| EP2679596B1 (de) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 Env-proteinvariante |
| CA3179312C (en) | 2013-03-15 | 2025-07-08 | Vapogenix, Inc. | ANALGESIC COMPOSITIONS COMPRISING HALOGENATED VOLATILE COMPOUNDS |
| US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
| US10058604B2 (en) | 2013-10-07 | 2018-08-28 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
| US9392814B2 (en) | 2014-06-06 | 2016-07-19 | Nicholas J. Singer | Delivery system for drinks |
| EP3069730A3 (de) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
| EP3072901A1 (de) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
| USD773313S1 (en) | 2015-06-23 | 2016-12-06 | Nicholas J. Singer | Package |
| EP3615005B1 (de) | 2017-04-28 | 2025-07-30 | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | Zusammensetzungen und verfahren zur verabreichung von impfungen |
| WO2021150471A1 (en) * | 2020-01-20 | 2021-07-29 | Huang Cai Gu | Liposome formulation of vilanterol trifenatate |
| US11278494B1 (en) | 2021-01-22 | 2022-03-22 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11357727B1 (en) | 2021-01-22 | 2022-06-14 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US11033495B1 (en) | 2021-01-22 | 2021-06-15 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12151024B2 (en) | 2021-01-22 | 2024-11-26 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| EP4415713A4 (de) | 2021-10-14 | 2025-08-06 | Pacira Pharmaceuticals Inc | Bupivacain-multivesikuläre liposomformulierungen und verwendungen davon |
| US12156940B1 (en) | 2024-05-20 | 2024-12-03 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12251468B1 (en) | 2024-05-20 | 2025-03-18 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
| US12251472B1 (en) | 2024-05-20 | 2025-03-18 | Pacira Pharmaceuticals, Inc. | Manufacturing of bupivacaine multivesicular liposomes |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2408387A2 (fr) † | 1975-06-30 | 1979-06-08 | Oreal | Compositions a base de dispersions aqueuses de spherules lipidiques |
| AU7128887A (en) * | 1986-02-10 | 1987-08-25 | Liposome Technology, Inc. | Controlled-release liposome delivery system |
| US4752425A (en) † | 1986-09-18 | 1988-06-21 | Liposome Technology, Inc. | High-encapsulation liposome processing method |
| DE4124252A1 (de) * | 1991-07-22 | 1993-01-28 | Knoll Ag | Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung |
| US5631237A (en) † | 1992-12-22 | 1997-05-20 | Dzau; Victor J. | Method for producing in vivo delivery of therapeutic agents via liposomes |
| FR2714601B1 (fr) * | 1993-12-30 | 1996-02-09 | Oreal | Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation. |
-
1995
- 1995-06-07 US US08/475,581 patent/US6007838A/en not_active Expired - Fee Related
-
1996
- 1996-06-06 ES ES96918002T patent/ES2159358T3/es not_active Expired - Lifetime
- 1996-06-06 DE DE69614385T patent/DE69614385T3/de not_active Expired - Fee Related
- 1996-06-06 JP JP09501158A patent/JP2000514035A/ja not_active Ceased
- 1996-06-06 CA CA002223808A patent/CA2223808A1/en not_active Abandoned
- 1996-06-06 WO PCT/US1996/008622 patent/WO1996040063A1/en not_active Ceased
- 1996-06-06 AT AT96918002T patent/ATE203898T1/de not_active IP Right Cessation
- 1996-06-06 DK DK96918002T patent/DK0831779T4/da active
- 1996-06-06 AU AU60365/96A patent/AU699055B2/en not_active Ceased
- 1996-06-06 PT PT96918002T patent/PT831779E/pt unknown
- 1996-06-06 EP EP96918002A patent/EP0831779B2/de not_active Expired - Lifetime
- 1996-06-06 IL IL12248696A patent/IL122486A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL122486A (en) | 2000-07-16 |
| IL122486A0 (en) | 1998-06-15 |
| CA2223808A1 (en) | 1996-12-19 |
| EP0831779A1 (de) | 1998-04-01 |
| AU6036596A (en) | 1996-12-30 |
| DK0831779T3 (da) | 2001-10-08 |
| PT831779E (pt) | 2001-11-30 |
| DE69614385D1 (de) | 2001-09-13 |
| ES2159358T3 (es) | 2001-10-01 |
| DK0831779T4 (da) | 2005-06-06 |
| DE69614385T3 (de) | 2005-05-25 |
| EP0831779B1 (de) | 2001-08-08 |
| US6007838A (en) | 1999-12-28 |
| JP2000514035A (ja) | 2000-10-24 |
| DE69614385T2 (de) | 2002-05-23 |
| EP0831779B2 (de) | 2005-01-19 |
| AU699055B2 (en) | 1998-11-19 |
| WO1996040063A1 (en) | 1996-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69614385D1 (de) | Verfahren zur herstellung einer liposomen-zubereitung | |
| ATE69723T1 (de) | Verfahren zur herstellung multilamellarer vesikel mit grossem waessrigem volumen. | |
| AT373147B (de) | Verfahren zur herstellung eines geformten und komprimierten therapeutischen praeparates mit verzoegerter wirkstoffabgabe | |
| DE3867866D1 (de) | Liposomzubereitung und ihre herstellung. | |
| ATA86885A (de) | Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge | |
| ATE80291T1 (de) | Maulbeerbaumextrakte enthaltende liposomzusammensetzung. | |
| ES8801118A1 (es) | Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado. | |
| GB2015464B (en) | Method of encapsulating biologically active materials in lipid vesicles | |
| ES8607906A1 (es) | Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares | |
| CA2233961A1 (en) | Stimulation of hair follicles | |
| BR1100687A (pt) | Formulações de agentes antineoplásticos lipossÈmicos com proporção elevada de droga com lipìdio | |
| CA2227761A1 (en) | Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers | |
| ATA60690A (de) | Nifedipinpräparate mit einer regulierten wirkstoffabgabe und verfahren zur herstellung derselben | |
| ES2077904T3 (es) | Obtencion y uso de preparados estables de liposomas en forma de pequeñas particulas. | |
| DE68904999D1 (de) | Verfahren zur herstellung dispergierbarer kolloidaler systeme aus amphiphilen lipiden in form von liposomen in submikrongroesse. | |
| HUT57590A (en) | Process for producing liposome compositions comprisings antiandrogenic active ingredient | |
| FI935051A0 (fi) | Lanolinderivat som penetrationfraemjande aemnen och anvaendning av dessa i preparat innehaollande laekemedel eller andra biologiskt aktiva substanser | |
| ES2163147T3 (es) | Perfeccionamientos de agentes antimicrobianos de accion prolongada o relativos a los mismos. | |
| ATE141503T1 (de) | Verfahren zur herstellung von wirkstoffhaltigen wässrigen liposomensuspensionen | |
| GR3036384T3 (en) | Medicament form for the delivery of collagenase to wounds and process for the preparation thereof | |
| DE69018258D1 (de) | Aktive Bestandteile enthaltende phospholipidische Liposome und Verfahren zu ihrer Herstellung. | |
| ATE290012T1 (de) | Methode für die herstellung von gereinigtem invasinprotein und seine anwendung | |
| DE59914774D1 (de) | Verfahren zur herstellung von liposomalen wirkstoffformulierungen | |
| DE3878696D1 (de) | Liposome, ihre herstellung und anwendung als vektor von arzneimitteln. | |
| DE69128455D1 (de) | Liposomale Mittel sowie Verfahren zu deren Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee | ||
| UEP | Publication of translation of european patent specification |
Ref document number: 0831779 Country of ref document: EP |